CIDE-C Activators encompass a range of chemical compounds that indirectly stimulate CIDE-C's functional role in lipid metabolism and energy homeostasis. Forskolin and IBMX, through the elevation of intracellular cAMP levels, activate protein kinase A (PKA), which in turn may enhance the lipolytic function of CIDE-C by promoting the breakdown of lipid droplets. Similarly, the availability of substrates such as palmitic and oleic acids can be conducive to the lipid droplet association and activity of CIDE-C, possibly facilitating the mobilization of stored fats. The metabolic modulators like rosiglitazone and pioglitazone exert their effects via PPARγ agonism, which can lead to an upregulated metabolic gene expression profile that includes pathways where CIDE-C is actively involved, thereby enhancing its functional role without directly influencing its expression levels.
Furthermore, compounds such as NAD+ and L-Carnitine influence CIDE-C activity by modifying its post-translational state and fatty acid flux, respectively. NAD+ serves as a substrate for sirtuins that may activate CIDE-C by deacetylation, whereas L-Carnitine is essential for fatty acid transport into mitochondria for β-oxidation, thereby increasing the substrate turnover for CIDE-C. Retinoic acid and GW 7647, through their roles as ligands for nuclear receptors, can shift theexpression of metabolic genes, creating a favorable environment for CIDE-C's involvement in lipid handling. The array of activators also includes choline, which by contributing to phospholipid synthesis, may support cellular membrane dynamics and lipid signaling, processes that are integral to the functional enhancement of CIDE-C. Epinephrine's role as an activator is also noteworthy; it binds to beta-adrenergic receptors, triggering a cascade that culminates in the activation of PKA, which can promote CIDE-C's activity by stimulating lipolysis and lipid mobilization. This mechanism is key to the body's response to energy demands, and epinephrine ensures that CIDE-C is functionally ready to orchestrate the rapid release of fatty acids when necessary. Collectively, these activators operate through distinct yet interconnected pathways, converging on the facilitation of CIDE-C's role in managing lipid distribution and utilization within cells, thus highlighting the multifaceted regulation of this protein's activity in energy homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises intracellular cAMP levels, which activates PKA. PKA phosphorylates various proteins that could enhance the lipolytic function of CIDE-C by promoting lipid droplet breakdown. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which increases cAMP levels and therefore could potentiate PKA activity, similarly enhancing CIDE-C's role in lipid metabolism. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $56.00 $186.00 $296.00 $655.00 $2550.00 $3500.00 $10500.00 | 4 | |
NAD+ acts as a substrate for sirtuins that can deacetylate proteins affecting their activity; this could activate CIDE-C by modifying its post-translational state, influencing lipid handling. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $112.00 $280.00 | 2 | |
Palmitic acid is a fatty acid that may integrate into lipid droplets, potentially increasing the substrate availability for CIDE-C's lipolytic activity. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $36.00 $102.00 $569.00 $1173.00 | 10 | |
Oleic acid, a monounsaturated fatty acid, could enhance CIDE-C activity by altering the lipid composition of droplets, making them more accessible for CIDE-C mediated lipid mobilization. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Rosiglitazone is a PPARγ agonist that can change the expression profile of metabolic genes, which may upregulate pathways where CIDE-C is functionally involved without affecting its expression. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrine stimulates lipolysis via beta-adrenergic receptors, increasing cAMP and activating PKA, which could enhance CIDE-C activity indirectly by mobilizing lipid stores. | ||||||
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $33.00 $77.00 $175.00 | 3 | |
L-Carnitine is essential for the transport of fatty acids into mitochondria for β-oxidation; it could enhance CIDE-C activity by increasing fatty acid flux and utilization. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid, through RAR and RXR nuclear receptors, can influence the gene expression of metabolic pathways, potentially enhancing the functional role of CIDE-C in lipid metabolism. | ||||||
GW 7647 | 265129-71-3 | sc-203068A sc-203068 sc-203068B sc-203068C | 1 mg 5 mg 10 mg 25 mg | $48.00 $167.00 $262.00 $648.00 | 6 | |
GW 7647 is a PPARα agonist that could indirectly enhance CIDE-C activity by upregulating peroxisomal and mitochondrial fatty acid oxidation pathways, increasing the demand for lipid mobilization. | ||||||